Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2022

MissionIRNewsBreaks – Tingo Inc. (TMNA) Engages Financial Advisor, Releases Annual Report

Posted on April 1, 2022 by MissionIR

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, is reporting its audited financial results for the year ended Dec. 31, 2021; the report included proforma financial results for Tingo Mobile because of the acquisition of the company, which is Tingo’s … Continue reading →

Posted in Tingo Inc. TMNA | Leave a comment

MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Earnings Call, 2021 Year-End Results Release Date

Posted on April 1, 2022 by MissionIR

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has said it will release its year-end 2021 financial report on Monday, May 2, 2022, after the market closes. The report will also … Continue reading →

Posted in Red White & Bloom Brands Inc. RWBYF | Leave a comment

MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Releases Q4, FY 2021 Financial Report, Operational Highlights

Posted on April 1, 2022 by MissionIR

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, is reporting financial results for the fourth quarter and full year for the period ended Dec. 31, 2021. Report highlights include record revenue for the company, which totaled $26.3 million for … Continue reading →

Posted in GreenBox POS. GBOX | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Continues to Showcase Ability to Improve Effectiveness of Existing Drug Brands

Posted on April 1, 2022 by MissionIR

Health and wellness drug product innovator Lexaria Bioscience has developed a patented technology — DehydraTECH (TM) — which enhances the bioavailability of fat-soluble drugs and molecules Lexaria continues to research DehydraTECH’s ability to improve the speed and bioavailability of cannabidiol … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment